RusnanoMedInvest and Domain Associates to invest $93m in development of three next-generation pharmaceuticals

• Russia fund in consortium to back U.S. pharma firms

  20 December 2012 Megan Davies, Reuters

  

  Russian state technology firm Rusnano, alongside a group of investors, is investing $93 million in three U.S.-based pharmaceutical firms to develop drugs to treat illnesses such as epilepsy, the investors said on Wednesday.